TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive Vince DeVita: Startup Funds For New Clinical Research Difficult To Get; Many Private Physicians More Capable Of Caring For Cancer Patients Than Those In Centers July 16, 1976
TCL Archive Improved Therapies For Cervical Cancer Said To Show Promise In Clinical Trials March 26, 2004
